Norepinephrine in septic patients - Friend or foe?

被引:6
作者
Theilmeier, G [1 ]
Booke, M [1 ]
机构
[1] Kliniken Main Taunus Kreises, Dept Anesthesiol, D-65812 Bad Soden, Germany
关键词
sepsis; norepinephrine; downregulation;
D O I
10.1016/S0952-8180(02)00504-4
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Norepinephrine (NE) is mostly used to treat severe hypotension. However, NE has potentially adverse vasoconstrictive effects on regional vascular beds of kidney, liver, and gut, with a potential for ensuing organ dysfunction. NE therefore is considered as a last reserve in otherwise refractory hypotension. During sepsis, a loss of catecholamine responsiveness occurs that is often interpreted as down-regulation of catecholamine receptors. Therefore, the doses of NE needed to maintain or restore blood pressure may be extremely high. Surprisingly, no adverse vasoconstriction with subsequent hypoperfusion occurs during sepsis, despite the high doses of ATE administered. Instead, NE rather causes an increase in blood flow and oxygen delivery. (C) 2003 by Elsevier Science Inc.
引用
收藏
页码:154 / 158
页数:5
相关论文
共 50 条
  • [31] Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine
    Sangeeta Mehta
    John Granton
    Anthony C Gordon
    Deborah J Cook
    Stephen Lapinsky
    Gary Newton
    Kris Bandayrel
    Anjuli Little
    Chuin Siau
    Dieter Ayers
    Joel Singer
    Terry CK Lee
    Keith R Walley
    Michelle Storms
    D James Cooper
    Cheryl L Holmes
    Paul Hebert
    Jeffrey Presneill
    James A Russell
    Critical Care, 17
  • [32] Timing of norepinephrine in septic patients: NOT too little too late
    Rachoin, Jean-Sebastien
    Dellinger, Richard P.
    CRITICAL CARE, 2014, 18 (06)
  • [33] Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients
    Martin, C
    Viviand, X
    Arnaud, S
    Vialet, R
    Rougnon, T
    CRITICAL CARE MEDICINE, 1999, 27 (09) : 1708 - 1713
  • [34] Glutamine supplementation in the critically ill: friend or foe?
    Oudemans-van Straaten, Heleen M.
    van Zanten, Arthur R. H.
    CRITICAL CARE, 2014, 18 (03):
  • [35] Enteral nutrition in circulatory shock: friend or foe?
    Shukla, Anuj
    Chapman, Marianne
    Patel, Jayshil J.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2021, 24 (02) : 159 - 164
  • [36] Hemofiltration in the early phase of sepsis: Friend or foe?
    de Pont, Anne-Corneli J. M.
    CRITICAL CARE MEDICINE, 2009, 37 (03) : 1125 - 1126
  • [37] The dichotomous role of immunoproteasome in cancer: Friend or foe?
    Chen, Boya
    Zhu, Haiying
    Yang, Bo
    Cao, Ji
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (05) : 1976 - 1989
  • [38] Caveolin-1 in sarcomas: friend or foe?
    Sainz-Jaspeado, Miguel
    Martin-Liberal, Juan
    Lagares-Tena, Laura
    Mateo-Lozano, Silvia
    Garcia del Muro, Xavier
    Tirado, Oscar M.
    ONCOTARGET, 2011, 2 (04) : 305 - 312
  • [39] Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: Few Concerns
    Khera, Daisy
    Suresh, Chethan
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2023, 27 (08) : 603 - 603
  • [40] Refractory septic shock to norepinephrine
    Meresse, Zoe
    Medam, Sophie
    Mathieu, Calypso
    Leone, Marc
    ANESTHESIE & REANIMATION, 2019, 5 (04): : 315 - 321